Project Grant RF1AG078351
Award Date 9/15/22
Completion Date 8/31/25
Dollars Obligated $5.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
- This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $2,181,250 in funding to the Seattle Institute For Biomedical And Clinical Research to develop small molecule inhibitors of the MSUT2 protein as a potential therapeutic approach for treating tauopathy disorders such as frontotemporal lobar degeneration, Alzheimer's disease, and related conditions. The project aims to optimize potent and brain-penetrant MSUT2 inhibitors and demonstrate...
- CHCHD10 in Tauopathy in Alzheimer's Disease and Related Dementias Research Project Case Western Reserve University's Office of Research Administration, in affiliation with University Hospitals of Cleveland, received a $431,750 Project Grant award from the National Institute on Aging (Aging Research program, CFDA 93.866) effective January 1, 2026, through December 31, 2027. The award funds biomedical research investigating the role of CHCHD10 (coiled-coil-helix-coiled-coil-helix domain containing...
- Grant Award Summary The National Institute on Aging (NIA) awarded $3,147,477 to The Regents of the University of California, San Francisco under the Aging Research program (CFDA 93.866) for the project "Aberrant Proteomes in Tauopathy: Revealing Functional Consequences via Multimodal Proteomics." The award period extends from June 1, 2025, through February 28, 2030. This research project combines mass spectrometry-based proteomics and functional genomics expertise to comprehensively...
- This $1,823,353 Project Grant awarded by the National Institute on Aging (CFDA 93.866 Aging Research) to the Seattle Institute For Biomedical And Clinical Research aims to elucidate the molecular mechanisms by which pathological tau protein causes neurodegeneration in Alzheimer's disease (AD) and related tauopathy disorders. The research project will leverage a C. elegans model of tauopathy to investigate the functional role of nuclear speckles, membraneless organelles involved in RNA...
- This Project Grant award of $320,000 from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) is supporting research at the University of Texas Medical Branch at Galveston (UTMB) to investigate the impact of pathological tau protein on alternative polyadenylation (APA) regulation in Alzheimer's disease. The study aims to comprehensively profile APA transcripts and gene expression in mouse primary hippocampal neurons expressing wild-type and mutant tau proteins....
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a Project Grant totaling $433,125.00 to The University of Texas Health Science Center at San Antonio effective September 15, 2025, through August 31, 2027, under the Aging Research program (CFDA 93.866). This exploratory/developmental grant funds research investigating whether extracellular tau protein modulates neurogenesis through the low-density lipoprotein receptor-related protein 1 (LRP1) pathway in adult-born granule...
- This $2,190,943 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a research study conducted by the University of Alabama at Birmingham (UAB) to examine the relationship between tau protein deposition and functional brain network health in individuals at risk for Alzheimer's disease (AD). The key objectives of the study are to: 1) Use tau positron emission tomography (PET) and resting-state functional magnetic resonance imaging (fMRI) to...
- This Project Grant award, with a total funding amount of $431,750, was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The award is for the development and evaluation of a novel immuno-gene therapy approach using a single-chain fragment variable (scFv) derived from an anti-tau oligomeric complex 1 (TOC1) antibody. The key objectives are to: 1) generate and validate the TOC1-scFv-HaloTag-Proteasome Degradation Signal (PDS)...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $433,125 will fund a study to investigate the relationship between microglia, neurons, and tau pathology in Alzheimer's disease. The research will utilize a novel model system of microglial co-cultures with hippocampal assembloids derived from patient-derived induced pluripotent stem cell (iPSC) lines with MAPT mutations and healthy controls. The goal is to explore how bidirectional changes...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded Massachusetts General Hospital $975,148 on May 15, 2025, under the Aging Research program (CFDA 93.866) to investigate the role of reactive astrocytes in tau protein propagation and clearance in Alzheimer's disease. The research project, which extends through February 28, 2030, will generate scientific knowledge regarding the mechanisms by which glial fibrillary acidic protein (GFAP) upregulation in astrocytes may...